
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression
Jingjing Cong, Xianwei Wang, Xiaohu Zheng, et al.
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 243-255.e5
Open Access | Times Cited: 293
Jingjing Cong, Xianwei Wang, Xiaohu Zheng, et al.
Cell Metabolism (2018) Vol. 28, Iss. 2, pp. 243-255.e5
Open Access | Times Cited: 293
Showing 1-25 of 293 citing articles:
NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 973
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 973
Metabolism of immune cells in cancer
Robert D. Leone, Jonathan D. Powell
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 516-531
Open Access | Times Cited: 609
Robert D. Leone, Jonathan D. Powell
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 516-531
Open Access | Times Cited: 609
NK Cell Metabolism and Tumor Microenvironment
Iñigo Terrén, Ane Orrantia, Joana Vitallé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 371
Iñigo Terrén, Ane Orrantia, Joana Vitallé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 371
Immunometabolism and natural killer cell responses
Katie L. O’Brien, David K. Finlay
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 282-290
Closed Access | Times Cited: 351
Katie L. O’Brien, David K. Finlay
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 282-290
Closed Access | Times Cited: 351
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 341
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 341
Targeting the untargetable KRAS in cancer therapy
Pingyu Liu, Yijun Wang, Xin Li
Acta Pharmaceutica Sinica B (2019) Vol. 9, Iss. 5, pp. 871-879
Open Access | Times Cited: 309
Pingyu Liu, Yijun Wang, Xin Li
Acta Pharmaceutica Sinica B (2019) Vol. 9, Iss. 5, pp. 871-879
Open Access | Times Cited: 309
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
Zhu Huang, Robert Blum, Davide Bernareggi, et al.
Cell stem cell (2020) Vol. 27, Iss. 2, pp. 224-237.e6
Open Access | Times Cited: 246
Zhu Huang, Robert Blum, Davide Bernareggi, et al.
Cell stem cell (2020) Vol. 27, Iss. 2, pp. 224-237.e6
Open Access | Times Cited: 246
Metabolic interventions in the immune response to cancer
David O’Sullivan, David E. Sanin, Edward J. Pearce, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 324-335
Closed Access | Times Cited: 239
David O’Sullivan, David E. Sanin, Edward J. Pearce, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 324-335
Closed Access | Times Cited: 239
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Zhanyu Wang, Chenfang Dong
Trends in cancer (2018) Vol. 5, Iss. 1, pp. 30-45
Closed Access | Times Cited: 234
Zhanyu Wang, Chenfang Dong
Trends in cancer (2018) Vol. 5, Iss. 1, pp. 30-45
Closed Access | Times Cited: 234
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Xiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1656-1667
Closed Access | Times Cited: 216
Xiaohu Zheng, Yeben Qian, Binqing Fu, et al.
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1656-1667
Closed Access | Times Cited: 216
Gluconeogenesis in cancer cells – Repurposing of a starvation-induced metabolic pathway?
Gabriele Grasmann, Elisabeth Smolle, Horst Olschewski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 1, pp. 24-36
Open Access | Times Cited: 209
Gabriele Grasmann, Elisabeth Smolle, Horst Olschewski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 1, pp. 24-36
Open Access | Times Cited: 209
Liver-Mediated Adaptive Immune Tolerance
Meijuan Zheng, Zhigang Tian
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 172
Meijuan Zheng, Zhigang Tian
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 172
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 156
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 156
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 156
Xinyang Zhong, Xuefeng He, Yaxian Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 156
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Rongchen Shi, Yi‐Quan Tang, Hongming Miao
MedComm (2020) Vol. 1, Iss. 1, pp. 47-68
Open Access | Times Cited: 147
Rongchen Shi, Yi‐Quan Tang, Hongming Miao
MedComm (2020) Vol. 1, Iss. 1, pp. 47-68
Open Access | Times Cited: 147
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity
Shoubao Ma, Jiazhuo Yan, Tasha Barr, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 137
Shoubao Ma, Jiazhuo Yan, Tasha Barr, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 8
Open Access | Times Cited: 137
Moonlighting functions of metabolic enzymes and metabolites in cancer
Chaoyun Pan, Bo Li, M. Celeste Simon
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3760-3774
Open Access | Times Cited: 113
Chaoyun Pan, Bo Li, M. Celeste Simon
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3760-3774
Open Access | Times Cited: 113
TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
Xueke Shi, Jin Yang, Shuzhi Deng, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 110
Xueke Shi, Jin Yang, Shuzhi Deng, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 110
Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
Shuai Wang, Qinchuan Wu, Tianchi Chen, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 467-478
Closed Access | Times Cited: 108
Shuai Wang, Qinchuan Wu, Tianchi Chen, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 467-478
Closed Access | Times Cited: 108
Tumor acidity: From hallmark of cancer to target of treatment
Alexey Bogdanov, Andrey Bogdanov, В. А. Чубенко, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 93
Alexey Bogdanov, Andrey Bogdanov, В. А. Чубенко, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 93
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 46
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure
Wei Liu, Wenhua You, Zhenwei Lan, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101448-101448
Open Access | Times Cited: 29
Wei Liu, Wenhua You, Zhenwei Lan, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101448-101448
Open Access | Times Cited: 29
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 21
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 21
Glycolysis, the sweet appetite of the tumor microenvironment
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith A. Clements, et al.
Cancer Letters (2024) Vol. 600, pp. 217156-217156
Open Access | Times Cited: 20
Zeinab Kooshan, Lilibeth Cárdenas-Piedra, Judith A. Clements, et al.
Cancer Letters (2024) Vol. 600, pp. 217156-217156
Open Access | Times Cited: 20